Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.3.1.900
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Statements of Operations [Abstract]      
Revenue
Operating expenses:      
Research and development, net of reimbursements $ 13,311,739 $ 12,267,313 $ 3,109,331
General and administrative 11,464,560 10,175,323 3,476,879
Depreciation expense $ 53,465 $ 37,908 1,560
Loss on disposition of equipment 4,122
Total operating expenses $ 24,829,764 $ 22,480,544 6,591,892
Loss from operations (24,829,764) (22,480,544) (6,591,892)
Other income (expense):      
Interest expense (7,868) (866) (2,508)
Gain (loss) on change in fair value of derivative liabilities 3,812,318 (2,206,099) (4,179,392)
Total other income (expense) 3,804,450 (2,206,965) (4,181,900)
Net loss $ (21,025,314) $ (24,687,509) $ (10,773,792)
Net loss per common share - basic and diluted $ (0.55) $ (0.90) $ (0.47)
Weighted average common shares outstanding - basic and diluted 38,158,480 27,363,748 22,752,752